VRTX vs GILD
VRTX 与 GILD 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | VRTXVERTEX PHARMACEUTICALS INC / MA | GILDGILEAD SCIENCES, INC. |
|---|---|---|
| 市值 | $121.07B | $161.64B |
| 市盈率(TTM) | 28.3 | 17.7 |
| 市净率 | 6.25 | 6.87 |
| 市销率 | 10.1x | 5.5x |
| 股息率 | — | 2.48% |
| 营收 | $12.22B(TTM) | $29.74B(TTM) |
| 营收同比增长 | 8.9% | 2.4% |
| 净利润 | $4.34B(TTM) | $9.22B(TTM) |
| 净利同比增长 | 838.1% | 1672.9% |
| 每股收益(稀释) | $16.85(TTM) | $7.35(TTM) |
| 息税前利润率 | 34.8% | 34.0% |
| 净资产收益率 | 20.4% | 36.2% |
| 投入资本回报率 | 25.4% | 21.6% |
| 一年总回报 | +4.4% | +18.8% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:VRTX vs GILD
| 指标 | VRTX | GILD |
|---|---|---|
| 期末价值 | $60.9K | $20.3K |
| 总回报 | +508.6% | +102.9% |
| 年化收益 (CAGR) | +19.1% | +7.1% |
| 波动率 | 33.0% | 25.7% |
| 夏普比率 | 0.58 | 0.25 |
| 索提诺比率 | 0.85 | 0.36 |
| 最大回撤 | -41.6% | -36.0% |
基于 2600 个共同交易日,2016-03-30 → 2026-07-31 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)